Titan Medical (TMDIF) Competitors

Pro-Dex (NASDAQ:PDEX) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

Does the media prefer PDEX or TMDIF?

In the previous week, Pro-Dex had 1 more articles in the media than Titan Medical. MarketBeat recorded 1 mentions for Pro-Dex and 0 mentions for Titan Medical. Pro-Dex's average media sentiment score of 1.87 beat Titan Medical's score of 0.00 indicating that Pro-Dex is being referred to more favorably in the media.

Company	Overall Sentiment
Pro-Dex	Very Positive
Titan Medical	Neutral

Which has better earnings and valuation, PDEX or TMDIF?

Titan Medical has lower revenue, but higher earnings than Pro-Dex. Titan Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$64.12M	2.53	$2.13M	$2.80	17.79
Titan Medical	$17.63M	2.52	$6.95M	$0.05	7.79

Do analysts prefer PDEX or TMDIF?

Pro-Dex currently has a consensus price target of $56.00, suggesting a potential upside of 12.40%. Given Pro-Dex's stronger consensus rating and higher possible upside, equities analysts plainly believe Pro-Dex is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is PDEX or TMDIF more profitable?

Pro-Dex has a net margin of 14.61% compared to Titan Medical's net margin of 0.00%. Pro-Dex's return on equity of 29.08% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	14.61%	29.08%	16.19%
Titan Medical	N/A	-82.31%	-51.47%

Do insiders and institutionals have more ownership in PDEX or TMDIF?

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Which has more volatility & risk, PDEX or TMDIF?

Pro-Dex has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500.

Summary

Pro-Dex beats Titan Medical on 14 of the 16 factors compared between the two stocks.